Proliferation and phenotypic changes of stromal cells in response to varying estrogen/androgen levels in castrated rats

Asian Journal of Andrology

Volumn 11, Issue 4, 2009, Pages 451-459

  Zhou, Ying ^a   Xiao, Xiang Qian ^a   Chen, Lin Feng ^b   Yang, Rui ^a   Shi, Jian Dang ^a   Du, Xiao Ling ^a   Klocker, Helmut ^c   Park, Irwin ^d   Lee, Chung ^d   Zhang, Ju ^a  

^a NANKAI UNIVERSITY   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANDROGEN; EOSIN; ESTROGEN; HEMATOXYLIN; MYOSIN HEAVY CHAIN;

ANDROGEN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CASTRATED MALE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM; ESTROGEN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PHENOTYPE; PROSTATE HYPERTROPHY; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; RAT; SMOOTH MUSCLE FIBER; STROMA CELL; WISTAR RAT;

ANIMALS; CELL PROLIFERATION; ESTRADIOL; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE PROTEINS; ORCHIECTOMY; RATS; RATS, WISTAR; STROMAL CELLS; TESTOSTERONE;

EID: 69749102504     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2009.28     Document Type: Article

References (38)

1. McNeal J. Pathology of benign prostatic hyperplasia. Insight into etiology. Urol Clin North Am 1990; 17: 477-86.
2. Suzuki K, Inaba S, Takeuchi H. Endocrinal environment of benign prostatic hyperplasia-relationships of sex steroid hormone levels with age and the size of the prostate. Nippon Hinyokika Gakkai Zasshi 1992; 83: 664-71.
3. Krieg M, Weisser H, Tunn S. Potential activities of androgen metabolizing enzymes in human prostate. J Steroid Biochem Mol Biol 1995; 53: 395-400.
4. Farnsworth WE. Estrogen in the etiopathogenesis of BPH. Prostate. 1999; 41: 263-74.
5. Shapiro E, Hartanto V, Lepor H. Quantifying the smooth muscle content of the prostate using double-immunoenzymatic staining and color assisted image analysis. J Urol 1992; 147: 1167-70.
6. Halayko AJ, Solway J. Molecular mechanisms of phenotypic plasticity in smooth muscle cells. J Appl Physiol 2001; 90: 358-68.
7. Zanellato AM, Borrione AC, Tonello M, Scannapieco G, Pauletto P, et al. Myosin isoform expression and smooth muscle cell heterogeneity in normal and atherosclerotic rabbit aorta. Arteriosclerosis 1990; 10: 996-1009.
8. Dennis JE, Charbord P. Origin and differentiation of human and murine stroma. Stem Cells 2002; 20: 205-214.
9. Schwartz SM, Campbell GR, Campbell JH. Replication of smooth muscle cells in vascular disease. Circ Res 1986; 58: 427-44.
10. Lin VK, Wang SY, Vazquez DV, C Xu C, Zhang S, et al. Prostatic stromal cells derived from benign prostatic hyperplasia specimens possess stem cell like property. Prostate 2007; 67: 1265-76.
11. Zhou Y, Yang R, Shi J, Du X, Wang K, et al. Proliferation and phenotypic modulation of stromal cells in relation to the expression of ERα in BPH. J Urol 2008; 179(4 suppl): 450.
12. Prins GS, Huang L, Birch L, Pu Y. The role of estrogens in normal and abnormal development of the prostate gland. Ann N Y Acad Sci 2006; 1089: 1-13.
13. King KJ, Nicholson HD, Assinder SJ. Effect of increasing ratio of estrogen: Androgen on proliferation of normal human prostate stromal and epithelial cells, and the malignant cell line LNCaP. Prostate 2006; 66: 105-14.
14. Nakhla AM, Khan MS, Romas NP, Rosner W. Estradiol causes the rapid accumulation of cAMP in human prostate. Proc Natl Acad Sci USA 1994; 91: 5402-5.
15. Zhang Z, Duan L, Du X, Ma H, Park I, et al. The proliferative effect of estradiol on human prostate stromal cells is mediated through activation of ERK. Prostate 2008; 68: 508-16.
16. Luo Y, Waladali W, Li S, Zheng X, Hu L, et al. 17beta-estradiol affects proliferation and apoptosis of rat prostatic smooth muscle cells by modulating cell cycle transition and related proteins. Cell Biol Int 2008; 32: 899-905.
17. Zhang J, Hess MW, Thurnher M, Hobisch A, Radmayr C, et al. Human prostatic smooth muscle cells in culture: Estradiol enhances expression of smooth muscle cell-specific markers. Prostate 1997; 30: 117-29.
18. Bektic J, Wrulich OA, Dobler G, Kofler K, Ueberall F, et al. Identification of genes involved in estrogenic action in the human prostate using microarray analysis. Genomics 2004; 83: 34-44.
19. Suzuki K, Takezawa Y, Suzuki T, Honma S, Yamanaka H. Synergistic effects of estrogen with androgen on the prostate-effects of estrogen on the prostate of androgen-administered rats and 5-alpha-reductase activity. Prostate 1994; 25: 169-76.
20. Niu YJ, Ma TX, Zhang J, Xu Y, Han RF, et al. Androgen and prostatic stroma. Asian J Androl 2003; 5: 19-26.
21. Fujimoto N, Suzuki T, Honda H, Kitamura S. Estrogen enhancement of androgen-responsive gene expression in hormone-induced hyperplasia in the ventral prostate of F344 rats. Cancer Sci 2004; 95: 711-5.
22. Jarred RA, Cancilla B, Prins GS, Thayer KA, Cunha GR, et al. Evidence that estrogens directly alter androgen-regulated prostate development. Endocrinology 2000; 141: 3471-77.
23. Sartore S, Scatena M, Chiavegato A, Faggin E, Giuriato L, et al. Myosin isoform expression in smooth muscle cells during physiological and pathological vascular remodeling. J Vasc Res 1994; 31: 61-81.
24. Xia SJ, Xu XX, Teng JB, Xu CX, Tang XD. Characteristic pattern of human prostatic growth with age. Asian J Androl 2002; 4: 269-71.
25. Levine AC, Kirschenbaum A, Gabrilove JL. The role of sex steroids in the pathogenesis and maintenance of benign prostatic hyperplasia. Mt Sinai J Med 1997; 64: 20-5.
26. Griffiths K, Coffey D, Cockett A. The regulation of prostatic growth. The Third International Consultation on Benign Prostatic Hyperplasia; Monaco 1995. pp 71-122.
27. Mitsumori K, Elwell MR. Proliferative lesions in the male reproductive system of F344 rats and B6C3F1 mice: Incidence and classification. Environ Health Perspect 1988; 77: 11-21.
28. Kim HS, Aikawa M, Kimura K, Kuro-o M, Nakahara K, et al. Ductus arteriosus. Advanced differentiation of smooth muscle cells demonstrated by myosin heavy chain isoform expression in rabbits. Circulation 1993; 88: 1804-10.
29. Sekiguchi K, Kurabayashi M, Oyama Y, Aihara Y, Tanaka T, et al. Homeobox protein Hex induces smemb/nonmuscle myosin heavy chain-B gene expression through the cAMP-responsive element. Circ Res 2001; 88: 52-8.
30. Miyauchi K, Aikawa M, Tani T, Nakahara K, Kawai S, et al. Effect of probucol on smooth muscle cell proliferation and dedifferentiation after vascular injury in rabbits: Possible role of PDGF. Cardiovasc Drugs Ther 1998; 12: 251-60.
31. Worth NF, Rolfe BE, Song J, Campbel GR. Vascular smooth muscle cell phenotypic modulation in culture is associated with reorganization of contractile and cytoskeletal proteins. Cell Motil Cytoskeleton 2001; 49: 130-45.
32. Song J, Wan Y, Rolfe BE, Campbell JH, Campbell GR. Effect of estrogen on vascular smooth muscle cells is dependent upon cellular phenotype. Atherosclerosis 1998; 140: 97-104.
33. Lee KL, Peehl DM. Molecular and cellular pathogenesis of benign prostatic hyperplasia. J Urol 2004; 172: 1784-91.
34. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004; 432: 332-7.
35. Lin VK, Wang D, Lee IL, Vasquez D, Fagelson JE, et al. Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue. Prostate 2000; 44: 193-203.
36. Hayward SW, Rosen MA, Cunha GR. Stromal-epithelial interactions in the normal and neoplastic prostate. Br J Urol 1997; 79: 18-26.
37. Farnsworth WE. Prostate stroma: Physiology. Prostate 1999; 38: 60-72.
38. Barclay WW, Woodruff RD, Hall MC, Cramer SD. A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer. Endocrinology 2005; 146: 13-8.